AKERS BIOSCIENCES, INC. (NASDAQ:AKER) Files An 8-K Other Events
Item 8.01 Other Events.
On November 18, 2020, Akers Biosciences, Inc. (the “Company”) issued a press release announcing that MyMD Pharmaceuticals, Inc. and the Company plan to hold a video conference for investors on Wednesday, November 18, 2020 at 4:15 p.m. ET to provide additional context on the integrated company, the clinical pipeline and drug development plan, and the commercial potential of the targeted indications. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
| 99.1 | Press release, dated November 18, 2020. |
Akers Biosciences, Inc. Exhibit
EX-99.1 2 ex99-1.htm REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals Baltimore,…
To view the full exhibit click here
